SERPINB6 antibodies are immunoreagents designed to detect SERPINB6, a 42 kDa intracellular serine protease inhibitor. These antibodies enable the study of SERPINB6’s function in inhibiting proteases like cathepsin G, thrombin, and chymotrypsin, which are implicated in inflammation, coagulation, and lysosomal stability .
A truncating mutation (p.E245X) in SERPINB6 causes autosomal-recessive nonsyndromic sensorineural hearing loss (DFNB91). Key findings include:
Loss of Protein Expression: Homozygous mutants showed absent SERPINB6 protein in leukocytes via Western blot .
Inner Ear Localization: SERPINB6 is expressed in cochlear and vestibular hair cells, where it protects against lysosomal enzyme leakage during stress .
Mechanism: SERPINB6 deficiency leads to unchecked protease activity, causing hair cell apoptosis .
Lysosomal Integrity: SERPINB6 overexpression in HeLa cells reduced lysosomal rupture under osmotic stress, as shown by LysoTracker assays .
Cytoprotection: SERPINB6 inhibits cathepsin G and kallikreins, preventing necrosis during oxidative or hypoxic stress .
Thrombin Inhibition: SERPINB6 (placental thrombin inhibitor) modulates coagulation by binding thrombin’s active site .
Senescent Cells: SILAC analysis revealed increased SERPINB6 secretion in senescent cells, linking it to age-related hemostatic changes .
Western Blot: Use RIPA buffer for extraction, 10% SDS-PAGE, and transfer to PVDF membranes .
IHC: Antigen retrieval with TE buffer (pH 9.0) enhances signal in formalin-fixed tissues .
SERPINB6 is a serine protease inhibitor belonging to the ovalbumin-serpin subfamily. It plays significant roles in regulating proteolytic processes within cells, particularly inhibiting cathepsin G, kallikrein-8, and thrombin . SERPINB6 is crucial for maintaining cellular integrity by safeguarding vital intracellular components from degradation by serine proteases, especially during stress responses . Research interest in SERPINB6 has increased due to its association with nonsyndromic progressive hearing loss, suggesting its protective role in inner ear hair cells against lysosomal content leakage during stress .
Several types of SERPINB6 antibodies are available for research purposes:
| Antibody Type | Host Species | Applications | Target Species | Examples |
|---|---|---|---|---|
| Polyclonal | Rabbit | WB, IHC, ELISA | Human, Mouse, Rat | ab97330, CAB9944, ab233229 |
| Monoclonal | Mouse | WB, IP, IF, IHC, ELISA | Mouse, Rat | sc-374535 (F-5) |
These antibodies target different epitopes of SERPINB6, with some recognizing specific regions (e.g., amino acids 50-300 or 180-300) while others target the full-length protein .
SERPINB6 typically appears at approximately 42-43 kDa in Western blot applications . The predicted band size is 43 kDa, which aligns with the observed molecular weight in experimental conditions. When performing Western blot validation, researchers should expect to see a clear band at this molecular weight, though slight variations may occur depending on post-translational modifications or the specific tissue/cell type being analyzed .
SERPINB6 antibodies have been validated for multiple experimental applications with varying degrees of effectiveness:
| Application | Recommended Dilution | Notes |
|---|---|---|
| Western Blot (WB) | 1:500-1:18000 | Most consistently reliable application across antibodies |
| Immunohistochemistry (IHC-P) | 1:20-1:200 | Effective for paraffin-embedded tissues |
| Immunofluorescence (IF/ICC) | 1:50-1:500 | Works well for cellular localization studies |
| Immunoprecipitation (IP) | 0.5-4.0 μg per 1-3 mg protein | Effective for protein-protein interaction studies |
| ELISA | Various | Antibody-dependent |
The optimal application may vary depending on the specific antibody, and titration is recommended when using a new antibody to determine the best working conditions for each experimental system .
For optimal antibody performance and longevity, SERPINB6 antibodies should be stored according to the following guidelines:
As supplied: 12 months from date of receipt at -20°C to -70°C
After reconstitution:
For liquid antibody formulations: Store at -20°C, aliquoting is recommended to avoid repeated freeze-thaw cycles
Some formulations contain preservatives like 0.02% sodium azide and 50% glycerol at pH 7.3
Proper storage is critical to maintaining antibody specificity and sensitivity in experimental applications.
Distinguishing between SERPINB6 isoforms and related family members requires careful antibody selection and experimental design:
Select epitope-specific antibodies: Choose antibodies targeting unique regions of SERPINB6 not conserved in other family members.
Use species-specific antibodies: Consider that in mice, the SERPINB6 gene family consists of three distinct genes (SERPINB6a, SERPINB6b, SERPINB6c) , while humans have multiple potential isoforms with variable N-terminal regions .
Perform validation experiments: Include appropriate positive and negative controls, along with knockout or knockdown samples if available.
Complementary approaches: Combine antibody-based detection with PCR-based methods to identify specific transcript variants.
Mass spectrometry validation: For absolute confirmation of protein identity, consider peptide sequencing.
When studying mouse models, note that mouse SERPINB6 shares 76% amino acid identity with human SERPINB6 , which may affect cross-reactivity of some antibodies.
Optimal sample preparation varies by application and sample type:
For Western Blot:
Use standard cell lysis buffers containing protease inhibitors
Recommended protein loading: 10-30 μg of total protein per lane
Denature samples at 95°C for 5 minutes in reducing sample buffer
For Immunohistochemistry:
Paraffin-embedded sections: Antigen retrieval with TE buffer pH 9.0 is often recommended
Alternatively, citrate buffer pH 6.0 may be used for antigen retrieval
Antibody concentration: ~20 μg/ml has been validated for DAB staining
Multiple tissue types have been validated, including prostate, kidney, liver, and cerebrum
For Immunofluorescence:
Fix cells with 4% paraformaldehyde for 10-15 minutes
Permeabilize with 0.1-0.5% Triton X-100
Block with 1-5% BSA or normal serum
Incubate with primary antibody at appropriate dilution (typically 1:50-1:500)
When facing issues with SERPINB6 antibody performance, consider these troubleshooting approaches:
For Weak Signal:
Optimize antibody concentration: Perform a titration experiment using a range of concentrations
Extend incubation time: Consider overnight incubation at 4°C for primary antibody
Enhance detection sensitivity: Use signal amplification systems or more sensitive detection methods
Improve antigen retrieval: Test different antigen retrieval buffers and conditions
Check protein expression: Verify SERPINB6 expression in your specific sample type
For Non-specific Binding:
Increase blocking stringency: Use 5% BSA or normal serum from the same species as the secondary antibody
Optimize washing steps: Increase washing duration and frequency
Pre-adsorb antibody: Pre-incubate with a blocking peptide if available
Reduce antibody concentration: Lower the primary antibody concentration
Validate with multiple antibodies: Use antibodies targeting different epitopes to confirm specificity
SERPINB6 has been linked to nonsyndromic progressive hearing loss (DFNB91), making it an important target in auditory research . Mutations in this gene affect the protection against lysosomal content leakage in inner ear hair cells during stress .
Antibodies can contribute to this research in several ways:
Localization studies: Immunohistochemistry can reveal SERPINB6 distribution in the inner ear
Protein interaction studies: Immunoprecipitation can identify binding partners relevant to hearing mechanisms
Expression analysis: Western blotting can quantify expression changes in disease models
Structural studies: Antibodies can help purify protein for structural analysis
Therapeutic development: Understanding SERPINB6's role could lead to targeted therapies
Researchers should select antibodies that have been validated in inner ear tissues or cell models relevant to hearing research. Combined approaches using both antibody-based detection and genetic models can provide comprehensive insights into SERPINB6's role in hearing physiology and pathology.
When analyzing SERPINB6 expression patterns:
Establish baseline expression: SERPINB6 is highly expressed in skeletal muscle, with significant expression in placenta, cardiac muscle, lung, liver, kidney, pancreas, and inner ear hair cells .
Consider cell-type specificity: Expression has been detected in keratinocytes, monocytes, mast cells (including mastocytoma lesions), and capillary endothelial cells .
Evaluate disease relevance:
In hearing loss: Monitor changes in inner ear expression
In inflammatory conditions: Assess expression in monocytes and granulocytes
In cancer studies: Compare expression between normal and tumor tissues
Account for species differences:
Quantitative analysis: Use appropriate normalization controls and consider both transcriptional and post-translational regulation.
For rigorous experimental design with SERPINB6 antibodies, include these controls:
Positive Controls:
Tissues with known high expression: Skeletal muscle, placenta
Recombinant SERPINB6 protein (for Western blot ladder control)
Negative Controls:
Primary antibody omission control
Isotype control (matching the primary antibody class)
Tissues known to have minimal SERPINB6 expression
SERPINB6 knockdown or knockout samples (if available)
Specificity Controls:
Peptide competition assay using the immunizing peptide
Multiple antibodies targeting different epitopes of SERPINB6
Detection with secondary antibody alone
Including these controls helps validate results and ensures proper interpretation of SERPINB6 detection in experimental systems.
An integrated multi-methodology approach enhances SERPINB6 research:
Complementary protein detection methods:
Combine antibody-based methods (Western blot, IHC, IF) with mass spectrometry for definitive protein identification
Use proximity ligation assay (PLA) to study protein-protein interactions in situ
Transcriptional analysis integration:
Functional studies:
Combine antibody detection with enzyme activity assays to correlate SERPINB6 presence with protease inhibition
Use cell-based assays to assess the functional impact of SERPINB6 expression changes
Genetic approaches:
Integrate CRISPR/Cas9 gene editing with antibody detection to study specific mutations
Correlate genotype with protein expression patterns in clinical samples
Imaging techniques:
Combine immunofluorescence with live-cell imaging to study dynamic processes
Super-resolution microscopy can reveal detailed subcellular localization
This multifaceted approach provides more robust data and comprehensive understanding of SERPINB6 biology than any single method alone.
SERPINB6 research is expanding into cancer and inflammatory disease areas:
In cancer research, SERPINB6 antibodies are being used to:
Evaluate expression in various tumor types, including prostate cancer and glioma
Study the protein's role in tumor progression and metastasis
Investigate connections to serine protease activity in the tumor microenvironment
Examine its potential as a biomarker for specific cancer subtypes
In inflammatory disease research:
SERPINB6 interacts with proteases found in monocytes and granulocytes, including cathepsin G
It forms stable complexes with these proteases, modulating inflammatory responses
Antibody-based detection can help track SERPINB6's role in acute and chronic inflammation
The protein's cytoplasmic localization allows unique regulation of intracellular proteolytic processes
Single-cell transcriptomics has recently revealed early molecular and immune alterations involving SERPINB6 in the serrated neoplasia pathway toward colorectal cancer , suggesting new research directions.
For effective co-localization studies:
Antibody selection considerations:
Choose antibodies raised in different host species to allow simultaneous detection
Verify that antibody pairs have compatible fixation requirements
Select antibodies with validated performance in immunofluorescence applications
Consider using directly conjugated antibodies to reduce cross-reactivity
Sample preparation optimization:
Test different fixation methods (paraformaldehyde, methanol, or combined approaches)
Optimize permeabilization conditions for intracellular access
Use sequential detection for challenging combinations
Consider antigen retrieval impact on epitope preservation
Imaging parameters:
Use appropriate filters to minimize spectral overlap
Perform sequential scanning for confocal microscopy
Include single-stained controls for setting acquisition parameters
Consider super-resolution techniques for detailed co-localization analysis
Analysis approaches:
Employ quantitative co-localization metrics (Pearson's coefficient, Manders' coefficients)
Use software tools designed for co-localization analysis
Perform z-stack imaging to ensure true co-localization in three dimensions
Consider live-cell imaging for dynamic interaction studies
Several advanced techniques can effectively study SERPINB6 interactions:
Co-immunoprecipitation (Co-IP):
Proximity Ligation Assay (PLA):
Allows visualization of protein interactions (<40nm) in situ
Provides spatial information about where interactions occur within cells
Can detect transient or weak interactions missed by traditional methods
FRET/BRET approaches:
Enable real-time monitoring of dynamic interactions
Can be performed in living cells
Provide quantitative data on interaction kinetics
Mass spectrometry-based interactomics:
Antibody-based pull-downs coupled with MS analysis
Identifies multiple interaction partners simultaneously
Can reveal previously unknown interactions
Structural studies:
X-ray crystallography or cryo-EM of SERPINB6-protease complexes
Provides atomic-level details of interaction mechanisms
Helps understand the unique inhibitory mechanism of SERPINB6
Understanding these interactions is particularly important given SERPINB6's known binding to proteases like cathepsin G, kallikrein-8, and thrombin , which underlie its protective functions in various tissues.